NBA free agency starts this weekend with the marquee attraction being Kevin Durant, torn Achilles and all. While there is much speculation about whether he will stay with Golden State or leave, I look at the question from a different perspective: can the Warriors afford to keep him? Understanding the Continue Reading
The Next Evolution In Investment Analytics
Summary:Analytics 1.0 = Find underpriced assetsAnalytics 1.1->1.9 = Keep frantically searching diminishing pool of underpriced assetsAnalytics 2.0 = Improve the quality of your own assets Most investors have no idea what they are good and bad at. They are stuck at Analytics 1.5. They need to evolve to Analytics 2.0. Continue Reading
Could The Fed Kill the P&C Trade?
P&C Stock Outperformance P&C Insurance stocks have been one of the better performing areas in the market YTD, largely driven by excitement over improvements in pricing. Several names are up over 30% on the year. When one looks a little closer at the pattern of outperformance, it becomes apparent that Continue Reading
IANS ALERT: D&O Reserves
I’m going to start a new semi-recurring feature of short posts called IANS ALERTs. Recall, from the recent post on pricing, I introduced the concept of IANS = Incurred And Never Spoken. These are shadow reserves that companies know they need but forget to tell the actuaries! When I come Continue Reading
Insuretech: Overhyped and Overvalued
Yes, I’m going to be the old codger who tells you things were better in the good old days when insurance companies were named for cities and farmers and America rather than sugar water and trees. Recent media leaks suggest Lemonade is looking to go public. Surely, it will be Continue Reading